All news

Cardinal Health extends CVS deal through 2032, trades 9.6% below target

Alpha Vantage · ad-hoc-news.de · · AI-summarised by FinFlash

Cardinal Health has extended its pharmaceutical distribution agreement with CVS Health through June 30, 2032. The company also reaffirmed its fiscal 2027 non-GAAP earnings-per-share guidance of USD 12.40 to USD 12.60. Cardinal Health stock was trading at EUR 222.75 in weekend trading on October 24, 2026.

Read original source

CAH company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.